Synthetic human Aβ42 peptide was prepared in two separate ways. Firstly the Aβ42 lyophilised powder was dissolved in TFA and dried under a nitrogen stream. The remaining film was dissolved in 100% HFIP to a concentration of 1 mg/ml, sonicated 5 min in a bath sonicator and dried under a nitrogen stream. The HFIP treatment was repeated twice more and on final dissolving the peptide was dispensed into microcentrifuge tubes. After drying under a nitrogen stream, the peptide was further dried under vacuum for 1–2 h to give a clear film.
The second method was to take the original peptide and dissolve it in 10% (w/v) NH4OH at 0.5 mg/ml. The peptide was incubated for 10 min at room temperature followed by sonication (5 min) and then dispensed (0.5 ml) into microfuge tubes. The NH4OH was removed by lyophilisation to yield a salt free fluffy white peptide. All aliquots from both methods were then stored at −80°C. Immediately prior to use, the HFIP- and NH4OH-treated and untreated Aβ42 were dissolved in 60 mM NaOH and the concentration determined by absorbance at 214 and 280 nm using extinction coefficients of 76848 M-1 cm-1 or 1490 M-1 cm-1, respectively. In all cases the resuspended peptide was analysed by mass spectrometry and the peptide found to be unmodified with no trace of HFIP or NH4OH.
Free full text: Click here